US Stocks Alert (Genzyme Corporation, SCSC, ONXX, GILD)
Genzyme Corporation (NASDAQ:GENZ) slid 0.19% to $72.05. Earlier this month, Genzyme Corp.’s board unanimously rejected a $69-a-share offer for the company by Sanofi-Aventis SA, describing the offer as “inadequate and opportunistic.” Genzyme Corporation is a biotechnology company. The Company’s product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant [...]
US Stocks to Watch (Genzyme Corporation, SCSC, ONXX, KLIC)
Genzyme Corporation (NASDAQ:GENZ) slid 0.46% to $72.10. Last week, Genzyme Corp.’s board unanimously rejected a $69-a-share offer for the company by Sanofi-Aventis SA, describing the offer as “inadequate and opportunistic.” Genzyme Corporation is a biotechnology company. The Company’s product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and [...]